Alexander Schmitz

Alexander is a Partner at Endeavour Vision, focusing on medical technology, digital health and diagnostics companies across multiple therapeutic areas.

Alexander brings more than two decades of business and strategy experience in both medical device and high-technology companies. He currently represents Endeavour Vision on the boards of Kenbi, Relievant MedSystems, Lumeon, Rapid Micro Biosystems (NASDAQ:RPID) and VentureMed, and advised on investments in Gynesonics, Nuvaira and V-Wave. He previously served on the boards of VertiFlex (acquired by Boston Scientific in 2019) and EndoStim. He is a member of the steering committee for PCR Innovators’ Day and serves as both a jury member and expert panelist for the Healthtech Summit.

Prior to joining the Endeavour Vision team, Alexander spent nine years with Biosensors International Group, an interventional cardiology company, where he served as vice president of business development. He previously worked with LogiSpring Ventures, MicroStrategy and McKinsey & Co.

Alexander holds an MBA from INSEAD and a BSFS, magna cum laude, from Georgetown University